A pharmaceutical company developing drugs for for treatment of dementia
Feb 15, 2022
Pharmasum Therapeutics has received support from the highly competitive Regional Research Fund for the project “A novel drug for treating dementia in Down syndrome” READ MORE >>
Dec 16, 2021
Pharmasum Therapeutics presented at the annual DNB Healthcare Venture session READ MORE >>
Nov 17, 2021
Pharmasum Therapeutics announces the publication of an article titled “Novel DYRK1A Inhibitor Rescues Learning and Memory Deficits in a Mouse Model of Down Syndrome” in the journal Pharmaceuticals. READ MORE >>